Bakunova Svetlana M, Bakunov Stanislav A, Wenzler Tanja, Barszcz Todd, Werbovetz Karl A, Brun Reto, Tidwell Richard R
Department of Pathology and Laboratory Medicine, School of Medicine, The University of North Carolina, Chapel Hill, North Carolina 27599-7525, USA.
J Med Chem. 2009 Aug 13;52(15):4657-67. doi: 10.1021/jm900805v.
A series of novel pyridyl analogues 1-18 of antiprotozoal drug 1,5-bis(4-amidinophenoxy)pentane (pentamidine) has been synthesized and tested for in vitro activities against Trypanosoma brucei rhodesiense, Plasmodium falciparum, and Leishmania donovani, and for cytotoxicity against mammalian cells. Antiprotozoal properties of compounds 1-18 depended on the placement of cationic moieties on the pyridine rings as well as the nature of substituents on the amidine groups. Diamidine 6 with cationic moieties adjacent to pyridine nitrogen atoms was the most promising compound in the series showing superior in vitro activities against T. brucei rhodesiense, P. falciparum, and L. donovani compared to pentamidine. An oral prodrug of diamidine 6, diamidoxime 9, administered at 25 mg/kg daily for 4 days, exhibited excellent antitrypanosomal efficacy in vivo curing all infected animals in the STIB900 acute mouse model of trypanosomiasis.
已合成了一系列抗寄生虫药物1,5-双(4-脒基苯氧基)戊烷(喷他脒)的新型吡啶类似物1-18,并测试了它们对罗德西亚布氏锥虫、恶性疟原虫和杜氏利什曼原虫的体外活性以及对哺乳动物细胞的细胞毒性。化合物1-18的抗寄生虫特性取决于吡啶环上阳离子部分的位置以及脒基上取代基的性质。在该系列中,吡啶氮原子相邻带有阳离子部分的二脒6是最有前景的化合物,与喷他脒相比,它对罗德西亚布氏锥虫、恶性疟原虫和杜氏利什曼原虫表现出优异的体外活性。二脒6的口服前药二脒肟9,以25mg/kg的剂量每日给药4天,在体内对锥虫病的STIB900急性小鼠模型中的所有感染动物均表现出优异的抗锥虫疗效。